Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Syndax Pharmaceuticals (SNDX) Receivables - Net (2024 - 2025)

Syndax Pharmaceuticals has reported Receivables - Net over the past 2 years, most recently at $38.0 million for Q4 2025.

  • Quarterly results put Receivables - Net at $38.0 million for Q4 2025, up 399.82% from a year ago — trailing twelve months through Dec 2025 was $38.0 million (up 399.82% YoY), and the annual figure for FY2025 was $38.0 million, up 399.82%.
  • Receivables - Net for Q4 2025 was $38.0 million at Syndax Pharmaceuticals, up from $25.4 million in the prior quarter.
  • Over the last five years, Receivables - Net for SNDX hit a ceiling of $38.0 million in Q4 2025 and a floor of $7.6 million in Q4 2024.